Ornidazole (Levo-)

CAS No. 166734-83-4

Ornidazole (Levo-)( (S)-Ornidazole | Levornidazole )

Catalog No. M26351 CAS No. 166734-83-4

Ornidazole Levo- is the levo-isomer of Ornidazole.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
25MG 42 In Stock
50MG 69 In Stock
100MG 111 In Stock
200MG 166 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ornidazole (Levo-)
  • Note
    Research use only, not for human use.
  • Brief Description
    Ornidazole Levo- is the levo-isomer of Ornidazole.
  • Description
    Ornidazole Levo- is the levo-isomer of Ornidazole.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (S)-Ornidazole | Levornidazole
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    protoporphyrinogen oxidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    166734-83-4
  • Formula Weight
    219.63
  • Molecular Formula
    C7H10ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (455.31 mM)
  • SMILES
    Cc1ncc(n1C[C@H](O)CCl)[N+]([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kaur N, Bhullar MS. Harvest time residues of pendimethalin and oxyfluorfen in vegetables and soil in sugarcane-based intercropping systems. Environ Monit Assess. 2015 May;187(5):221.
molnova catalog
related products
  • DS-2969b

    DS-2969b (DS 11960558) is a novel orally active GyrB inhibitor, inhibits the supercoiling activity of C. difficile DNA gyrase with IC50 of 20 ng/mL.

  • Q203

    A novel potent anti-tuberculosis agent targeting cytochrome b subunit qcrB, inhibits M. tuberculosis H37Rv with MIC50 of of 2.7 nM.

  • Cyproconazole

    Cyproconazole is a triazole fungicide. It is used agriculturally for protection of crops against a wide variety of fungal pathogens.Cyproconazole has been shown to cause a dose dependent inhibition of progesterone production in human placental cells in vitro.